No data available
Ovartix is a women’s health drug discovery company that harnesses large-scale human multi-omics data, state-of-the-art cell engineered and animal models to identify, validate and develop next-generation therapeutics for ovary-centric female reproductive disorders, such as infertility and menopause
Sustainable bio-based materials for fashion
Spun out from the Karolinska Institute in 2013, Pelago Bioscience AB was founded by the inventors of the Cellular Thermal Shift Assay (CETSA®) to both develop the method and to provide a commercial service for organisations wanting to use the method.. . CETSA measures compound binding under actual physiological conditions within either a cellular of lysate environment. The assay relies on a well-established observation that compound binding with a protein will change its thermal denaturation point, meaning that at a given denaturation temperature there will be a difference in the abundance of the intact protein as compared with a negative control. It is the only technique that will confirm such target engagement is occurring and provides ‘real world’ EC50 values for your compound in cells.. . The company controls the patents on CETSA and delivers in situ target engagement studies to accelerate preclinical and clinical drug discovery and diagnostics development. Using CETSA data and applications, drug discovery R&D companies are able to make better and more informed decisions at earlier stages in their projects.
Perla Development is a training, facilitation and executive coaching consultancy, specialising in leadership, management and professional development, (primarily within the life sciences sector). Founded in 2014, and run by Liz Mercer, Perla Development offers executive coaching, leadership and management development programmes, workshop design and delivery, team development and meetings facilitation.
Perla’s two flagship offerings are the Management Essentials Programme for first line leaders and the Expert Leader Programme for middle to senior leaders in the life sciences. Both these programmes are open programmes with participation from across the industry. Liz also works with many clients providing training and development in a variety of topics: coaching skills, feedback, delegation, difficult conversations, managing performance, leading change, motivation and engagement, to name but a few. Her recent clients include, OMass Therapeutics, Charm Therapeutics, Microbiotica Ltd, T-therapeutics, Alchemab, Vernalis, Besins Healthcare and Ensocell.
Liz utilises a number of industry-leading models and tools in her work such as the Myers Briggs Type Indicator (MBTI), Korn Ferry competencies, Hogan, 360 feedback tools and the Key Polarity Indicator.
To get in touch with Liz at Perla Development you can:
• message directly, or call 07825 229686
• email her at [email protected]
• or message via LinkedIn https://www.linkedin.com/in/lizmercer1/
/>
Perla’s two flagship offerings are the Management Essentials Programme for first line leaders and the Expert Leader Programme for middle to senior leaders in the life sciences. Both these programmes are open programmes with participation from across the industry. Liz also works with many clients providing training and development in a variety of topics: coaching skills, feedback, delegation, difficult conversations, managing performance, leading change, motivation and engagement, to name but a few. Her recent clients include, OMass Therapeutics, Charm Therapeutics, Microbiotica Ltd, T-therapeutics, Alchemab, Vernalis, Besins Healthcare and Ensocell.
Liz utilises a number of industry-leading models and tools in her work such as the Myers Briggs Type Indicator (MBTI), Korn Ferry competencies, Hogan, 360 feedback tools and the Key Polarity Indicator.
To get in touch with Liz at Perla Development you can:
• message directly, or call 07825 229686
• email her at [email protected]
• or message via LinkedIn https://www.linkedin.com/in/lizmercer1/
/>
Pharma International provides global pharmaceutical regulatory consultancy services, with an emphasis on the emerging markets. Fully licensed by Swissmedic, Pharma International is authorised to trade in biotechnology, pharmaceuticals and medical devices internationally – as well as providing Swiss Qualified Person services. Seminars on regulatory affairs, especially Asia including ASEAN, China, Korea and India, are conducted regularly and can be adapted to in-house requirements.
Regulatory Consultancy
PharmaMedic provides a comprehensive outsourced virtual medical and regulatory affairs service for start-ups, mid to late-stage biopharma, as well as consumer health organisations, medical device companies, and academic centres. We deliver our virtual medical and regulatory affairs solutions through a team of experienced pharmaceutical consultants. We provide a range of flexible services supporting start-ups, product launches, and large pharma teams.
For more information visit our website https://pharmamedic.co/
Download our capabilities brochure here https://pharmamedic.co/wp-content/uploads/2020/09/PMC-Capabilities.pdf
Watch our Member Showcase Video https://bit.ly/3rzlfvd
For more information visit our website https://pharmamedic.co/
Download our capabilities brochure here https://pharmamedic.co/wp-content/uploads/2020/09/PMC-Capabilities.pdf
Watch our Member Showcase Video https://bit.ly/3rzlfvd
No data available
Founded in the UK in 2002, Pharmidex provides high quality experimental preclinical ADMET/PK data, critical to the progression of drug discovery programmes. We have comprehensive in-house laboratory facilities as well as extensive in-vitro and in-vivo assay options. This enables us to provide tailored studies designed to meet individual project needs. Through extensive knowledge of drug discovery and development, Pharmidex has been able to deliver a high level of customer satisfaction and forge several strategic international alliances, focusing on operations in the following areas: in vitro ADMET, in-vivo Pharmacology, CNS Drug Discovery, Bioanalysis, Metabolite Identification, Bioimaging, and Zebrafish.